For many of the 30 million people affected by rare disease in the EU, lack of effective treatments and discrepancies in access and diagnosis are still common issues. Strong political will, innovation and further cooperation between countries remain vital to improve outcomes and transform their quality of life. Join this virtual live policy event Unlocking innovation and access for rare disease patients in Europe, a Biogen initiative, in collaboration with Reuters Events and EU40, that will address the future of European collaboration on rare diseases. Join this free event, open to all in the rare disease community on Monday 22nd February, 2:00-3:45pm CETregister here.